Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status

Trial Details

NCT ID

NCT06356714

Phase

PHASE2

Sponsor

Sun Jing

Status

RECRUITING

Cancer Type

Colorectal Cancer

Interventions

• Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens

Locations (sample)

• Nanjing, Jiangsu, China|32.06167,118.77778

Key Eligibility Criteria

• Age ≥ 18 years old, gender is not limited;
• Colorectal adenocarcinoma confirmed by pathologic histology and/or cytology and imaging;
• Have 1 or more measurable lesions with a longest diameter of at least 10 mm as determined by spiral CT scanning; and a diameter of at least 20 mm a…
• Prior second- or third-line therapy for advanced or metastatic colorectal cancer with potentially harmful SD status. The potentially hazardous SD (…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.